Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Affymax And Takeda Report Phase 2 Analyses Of Hematide™/peginesatide In Hemodialysis
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2137785" data-attributes="member: 124445"><p>Affymax, Inc. (Nasdaq: AFFY) and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease (CKD). The data provide hypotheses for further investigation of this agent in anemia management in this patient population. The findings were presented in three separate posters at the National Kidney Foundation (NKF) Annual Meeting being held in Orlando, Florida. According to the U.S... <a href="http://feedads.g.doubleclick.net/~a/11H-HuqJ06JzCJJwQXyecSzESCc/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/11H-HuqJ06JzCJJwQXyecSzESCc/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/11H-HuqJ06JzCJJwQXyecSzESCc/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/11H-HuqJ06JzCJJwQXyecSzESCc/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/h7TVsJmkgt4" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/h7TVsJmkgt4/3BnS" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2137785, member: 124445"] Affymax, Inc. (Nasdaq: AFFY) and Takeda Global Research & Development Center, Inc., U.S., today announced data from several post hoc analyses of Phase 2 clinical trials that evaluated Hematide/peginesatide in dialysis patients with anemia in chronic kidney disease (CKD). The data provide hypotheses for further investigation of this agent in anemia management in this patient population. The findings were presented in three separate posters at the National Kidney Foundation (NKF) Annual Meeting being held in Orlando, Florida. According to the U.S... [URL="http://feedads.g.doubleclick.net/~a/11H-HuqJ06JzCJJwQXyecSzESCc/0/da"][IMG]http://feedads.g.doubleclick.net/~a/11H-HuqJ06JzCJJwQXyecSzESCc/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/11H-HuqJ06JzCJJwQXyecSzESCc/1/da"][IMG]http://feedads.g.doubleclick.net/~a/11H-HuqJ06JzCJJwQXyecSzESCc/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/h7TVsJmkgt4[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/h7TVsJmkgt4/3BnS]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top